Get the Stockscreener App
76.55
0.41%
0.31
Henry Schein Inc stock is traded at $76.55, with a volume of 1.09M.
It is up +0.41% in the last 24 hours and up +5.09% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$76.24
Open:
$76.01
24h Volume:
1.09M
Relative Volume:
0.74
Market Cap:
$9.01B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
31.37
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
+3.98%
1M Performance:
+5.09%
6M Performance:
+7.70%
1Y Performance:
-0.62%
1-Day Range:
$75.54
$76.68
1-Week Range:
$72.78
$77.46
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
76.55 | 8.98B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
813.80 | 100.66B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
346.00 | 66.83B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
198.18 | 47.12B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
AHG
Akso Health Group Adr
|
1.35 | 744.44M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Aug-26-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Do Wall Street Analysts Like Henry Schein Stock? - MSN
Did Henry Schein’s (HSIC) Expanded vVARDIS Deal Quietly Recast Its Minimally Invasive Dental Strategy? - simplywall.st
Henry Schein Expands Partnership with vVARDIS - Zenopa
California Public Employees Retirement System Sells 120,408 Shares of Henry Schein, Inc. $HSIC - MarketBeat
How Henry Schein’s (HSIC) Expanded Curodont Deal Could Reshape Its Technology-Enabled Margin Story - Yahoo Finance
Why Henry Schein (HSIC) Stock Is Up Today - The Globe and Mail
Henry Schein (HSIC) Announces Extension of Strategic Partnership Agreement - GuruFocus
Henry Schein, Inc. (HSIC): A Bull Case Theory - Finviz
Henry Schein One and AWS leverage generative AI to revolutionize dentistry - Amazon Web Services (AWS)
SVB Wealth LLC Invests $1.42 Million in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein to renominate KKR designees to board for 2026 term By Investing.com - Investing.com Nigeria
Henry Schein to renominate KKR designees to board for 2026 term - Investing.com
Henry Schein Extends Strategic Partnership with KKR - TipRanks
Barclays Initiates Henry Schein With Overweight Rating, $86 Price Target - marketscreener.com
Henry Schein, Inc. $HSIC Shares Bought by Marshall Wace LLP - MarketBeat
Gabelli Funds LLC Sells 16,750 Shares of Henry Schein, Inc. $HSIC - MarketBeat
Resistance Check: Why Henry Schein Inc. stock remains undervaluedDollar Strength & Risk Controlled Daily Plans - BỘ NỘI VỤ
Arrowstreet Capital Limited Partnership Has $21.12 Million Holdings in Henry Schein, Inc. $HSIC - MarketBeat
409,100 Shares in Henry Schein, Inc. $HSIC Acquired by Oribel Capital Management LP - MarketBeat
Burgundy Asset Management Ltd. Sells 27,936 Shares of Henry Schein, Inc. $HSIC - MarketBeat
HSIC Stock Benefits From Expanded Partnership With vVARDIS - MSN
Stenger Family Office LLC Purchases New Stake in Henry Schein, Inc. $HSIC - MarketBeat
Invesco Ltd. Cuts Stake in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Can Make Your Portfolio Smile (NASDAQ:HSIC) - Seeking Alpha
Henry Schein (HSIC): Revisiting Valuation After Expanded vVARDIS Distribution Deal in Preventive Dentistry - Sahm
Custom Nightguards Initiated in Dentrix Now Available from Henry Schein - Dentistry Today
Norges Bank Invests $89.48 Million in Henry Schein, Inc. $HSIC - MarketBeat
2025 Healthy Outcomes Conference: Henry Schein Canada reducing disability leave claims with wellness program - Benefits Canada.com
Why Is Henry Schein (HSIC) Up 1.2% Since Last Earnings Report? - Yahoo Finance
Hsbc Holdings PLC Raises Stake in Henry Schein, Inc. $HSIC - MarketBeat
How Investors May Respond To Henry Schein (HSIC) Gaining Exclusive U.S. Rights To Drill-Free Cavity Treatment - simplywall.st
Q3 Rundown: Henry Schein (NASDAQ:HSIC) Vs Other Dental Equipment & Technology Stocks - Barchart.com
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo Finance
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Skandinaviska Enskilda Banken AB publ Acquires 19,688 Shares of Henry Schein, Inc. $HSIC - MarketBeat
Curodont Drill-Free Caries Treatment to Be Distributed by Henry Schein Across U.S. Dental Market - Orthodontic Products
M.D. Sass LLC Acquires Shares of 1,084,196 Henry Schein, Inc. $HSIC - MarketBeat
Russell Investments Group Ltd. Boosts Stake in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein, Inc. $HSIC Shares Purchased by Prudential Financial Inc. - MarketBeat
A Closer Look at Henry Schein (HSIC) Valuation Following Recent Share Price Momentum - Yahoo Finance
Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Henry Schein expands vVARDIS distribution deal for drill-free cavity treatment - Investing.com Nigeria
Henry Schein expands vVARDIS distribution deal for drill-free cavity treatment By Investing.com - Investing.com South Africa
Henry Schein Becomes Exclusive US Distributor of vVARDIS' Curodont Treatment in January - marketscreener.com
Henry Schein expands exclusive distribution partnership with vVARDIS - TipRanks
Henry Schein, Inc. Expands Partnership with Vvardis - marketscreener.com
HSIC Stock Set to Benefit From Henry Schein One's Workflow Launch - sharewise.com
Schroder Investment Management Group Buys 936,471 Shares of Henry Schein, Inc. $HSIC - MarketBeat
Is There Opportunity in Henry Schein After 18% Rally and Digital Dentistry Expansion? - simplywall.st
Henry Schein, Inc. $HSIC Shares Sold by Charles Schwab Investment Management Inc. - MarketBeat
Henry Schein One to unveil smarter workflows at GNYDM - DrBicuspid.com
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
2.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):